An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
NCT ID: NCT04664920
Last Updated: 2020-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2020-06-08
2020-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Exergame intervention arm.
exergame
motor-cognitive training device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exergame
motor-cognitive training device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Live in long-term care facility "de Wingerd"
* Being diagnosed with major neurocognitive disorder by a specialist doctor
* Standing straight for minimal 10 minutes without aids
* Visual acuity with correction sufficient to work on a TV screen
Exclusion Criteria
* Severe acute or uncontrolled health problems (e.g. recent cardiac infarction, uncontrolled diabetes or hypertension)
* Orthopaedic or neurological diseases that inhibit Exergame training
* Rapidly progressive or terminal illness
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Davy Vancampfort
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davy Vancampfort
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
De Wingerd
Leuven, Vlaams Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
052020
Identifier Type: -
Identifier Source: org_study_id